Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.

Published in: Diabetologia (2023)

This study was funded by Novo Nordisk A/S.

Keyphrases